According to Biotest
's latest financial reports the company's current revenue (TTM ) is ยฃ0.60 Billion. In 2023 the company made a revenue of ยฃ0.58 Billion an increase over the revenue in the year 2022 that were of ยฃ0.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | ยฃ0.60 B | 3.54% |
2023 | ยฃ0.58 B | 29.16% |
2022 | ยฃ0.45 B | 1.41% |
2021 | ยฃ0.44 B | 7.62% |
2020 | ยฃ0.41 B | 15.36% |
2019 | ยฃ0.35 B | -3.44% |
2018 | ยฃ0.37 B | 67.41% |
2017 | ยฃ0.22 B | -51.82% |
2016 | ยฃ0.45 B | 4.52% |
2015 | ยฃ0.43 B | -9.45% |
2014 | ยฃ0.48 B | 20.26% |
2013 | ยฃ0.40 B | 13.91% |
2012 | ยฃ0.35 B | -5.33% |
2011 | ยฃ0.37 B | 16.73% |
2010 | ยฃ0.32 B | -16.2% |
2009 | ยฃ0.38 B |